Anti-adhesion cancer therapy

Cancer and Metastasis Reviews

Volumn 17, Issue 2, 1998, Pages 177-185

  Glinsky, Gennadi V ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Cancer Research Center   (United States)

Author keywords

Apoptosis; Cancer therapy; Drug resistance; Metastasis; Synthetic glycoamines

Indexed keywords

ANTIMETASTATIC AGENT; BETA GALECTIN 3; CELL ADHESION MOLECULE; CISPLATIN; DOXORUBICIN; GALECTIN; GLYCOAMINE; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CANCER RESISTANCE; CELL ADHESION; DRUG MECHANISM; GENE TRANSFER; HUMAN; HUMAN CELL; MELANOMA B16; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS;

EID: 0031850999     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006050302406     Document Type: Review

References (58)

1. Glinsky GV: Cell adhesion and metastasis: Is the site specificity of cancer metastasis determined by leukocyte-endothelial cell recognition and adhesion? Crit Rev Onc/Hemat 14: 229-278, 1993
2. Glinsky GV, Glinsky VV: Apoptosis and metastasis: A superior resistance of metastatic cancer cells to the programmed cell death. Cancer Lett 101: 43-51, 1996
3. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CN: Apoptosis and metastasis: Increase apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisma. Cancer Lett 115: 185-193, 1997
4. Glinsky GV: Apoptosis in metastatic cancer cells. Crit Rev Oncol/Hemat 25: 175-186, 1997
5. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y, Irimura T: Increased expression of sialyl Lewis X antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637, 1993
6. Sawada R, Tsuboi S, Fukuda M: Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer with distinct metastatic potential. J Biol Chem 269: 1425-1431, 1994
7. Sawada R, Lowe JB, Fukuda M: E-selectin-dependent adhesion efficiency of colonie carcinoma cells is increased by genetic manipulation of their cell surface lamp-1 expression levels. J Biol Chem 268: 12675-12681, 1993
8. Goetz DJ, Ding H, Luscinscas FW: A colon carcinoma cell lines adheres to P-selectin under flow conditions independent of PSGL-1. Mol Biol Cell 6: 410a, 1995
9. Baeckstrom D, Zhang K, Asker N, Ruetschi U, Ek M, Hansson GC: Expression of leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line. J Biol Chem 270, 13688-13692, 1995
10. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314, 1994
11. Edelman GM: Cell adhesion and the molecular processes of morphogenesis. Annu Rev Biochem 54: 135-169, 1985
12. Rutishauser U, Acheson A, Hall A, Mann DM, Sunshine J: The neural cell adhesion molecule (NCAM) as a regulator cell-cell interactions. Science (Washington DC), 240: 53-57, 1988
13. Finne J: Occurence of unique polysialosyl carbohydrate units in glycoproteins of developing brain. J Biol Chem 257: 11966-11970, 1982
14. Scheidegger EP, Lackie PM, Papay J, Roth J: In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. Lab Invest 70: 95-106, 1994
15. Komminoth P, Roth J, Lackie PM, Bitter-Suermann D, Heitz PU: Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol 139: 297-304, 1991
16. Linnemann D, Raz A, Bock E: Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity. Int J Cancer 43: 709-712, 1989
17. Andersson AM, Moran N, Gaardsvoll H, Linnemann D, Bjerkvig R, Laerum OD, Bock E: Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells. Int J Cancer 47: 124-129, 1991
18. Yamashita K, Ohkura T, Tachibana Y, Takasaki S, Kobata A: Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J Biol Chem 259: 10834-10840, 1984
19. Dennis JW, Laferte S: Asn-linked oligosaccharides and the metastatic phenotype. In: Reading CL, Hakomori S, Markus DM (eds) Altered Glycosylation in Tumor Cells. Alan R. Liss. New York, 257-267, 1988
20. Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N: Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 92: 8754-8758, 1995
21. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N: Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 271: 13811-13815, 1996
22. Breen F., Steele G Jr, Mercurio AM: Role of the E-cadherin/ a-catenin complex in modulating cell-cell and cell-matrix adhesive properties of invasive colon carcinoma cells. Ann Surg Oncol 2: 378-385, 1995
23. Zheng M, Fang H, Hakomori S: Functional role of N-glycosylation in α5β1 integrin receptor: De-N-glycosylation induces dissociation or altered association of α5 and β1 subunits and concomitant loss of fibronectin binding activity. J Biol Chem 269: 12325-12331, 1994
24. Dennis JW: Effect of swainsonine and polyinosinic: polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res 46: 5131-5136, 1986
25. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW: Reduced contact inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 130: 383-392, 1995
26. Goss PE, Baptiste J, Fernandes B, Baker M, Dennis JW: A phase 1 study of swainsonine in patients with advanced malignancies. Cancer Res 54: 1450-1457, 1994
27. Dennis JW, White SL, Freer AM, Dime D: Carbonoyloxy analogs of the anti-metastatic drug swainsonine: Activation in tumor cells by esterase. Biochem Pharmacol 46: 1459-1466, 1993
28. Fukuda M: Possible role of tumor-associated carbohydrate antigens. Cancer Res 56: 2237-2244, 1996
29. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318, 1996
30. Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB: Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Cancer Res 56: 5319-5324, 1996
31. Glinsky GV, Mossine VV, Price JE, Bielenberg D, Glinsky VV, Ananthaswamy HN, Feather MS: Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs. Clin Exp Metastasis 14: 253-267, 1996
32. Peletskaya EN, Glinsky GV, Deutscher SL, Quinn TP: Identification of peptide sequences that bind the Thomsen-Friedenreich cancer-associated glycoantigen from bacteriophage peptide display libraries. Mol Diversity 2: 13-18, 1996
33. Peletskaya EN, Glinsky VV, Glinsky GV, Deutscher SL, Quinn TP: Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries. J Mol Biol 270: 374-384, 1977
34. Glinsky GV: Failure of apoptosis and cancer metastasis. The Medical Intelligence Unit, R.G. Landes Company, Austin/ Georgetown, TX, 210 pp. 1998
35. Freireich EJ: Treatment of malignancies, past and present. Hosp Pract 28: 109-126, 1993
36. St. Croix B, Rak JW, Kapitain S, Sheehan C, Graham CH, Kerbel RS: Hyaluronidase reverses adhesion-dependent multicellular drug resistance in mammary carcinoma cells. J Natl Cancer Inst 88: 1285-1296, 1996
37. Kerbel RS, Rak J, Kobayashi H, Man MS, St. Croix B, Graham CH: Multicellular resistance: A new paradigm to explain aspects of aquired drug resistance of solid tumors. Cold Spring Harbor Symp Quant Biol 59: 661-672, 1994
38. Kerbel RS, St. Croix B, Rak J, Graham C: Is there a role for anti-adhesives as chemosensitizers in the treatment of solid tumors by chemotherapy? Bull Inst Pasteur 92: 248-256, 1995
39. Ohshima S, Ishimaru Y, Honda M, Ohkawara S, Ogawa M: A monoclonal antibody disrupting cell-cell adhesion of rat ascites hepatoma cells. Cell Tissue Res 273: 363-370, 1993
40. Allen HJ, Porter C, Gamarra M, Piver MS, Johnson EA: Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. Exp Cell Biol 55: 194-208, 1987
41. Kitsuki H, Katano M, Morisaki T, Torisu M: CEA-mediated homotypic aggregation of human colorectal carcinoma cells in a malignant effusion. Cancer Lett 88: 7-13, 1995
42. Akahani S, Nangia-Makker P, Inohara H, Kim H-RC, Raz A: Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57: 5272-5276, 1997
43. Yang RY, Hsu DK, Liu F-T: Expression of galectin-3 modulates T-cell growth and apoplosis. Proc Natl Acad Sci USA 93: 6737-6742, 1996
44. Glinsky GV: Glycoamines: Biochemistry of a new class of humoral tumor markers. J Tumor Markers Oncology 4: 193-221, 1989
45. Glinsky GV: Glycoamines: Structural-functional characterization of a new class of humoral tumor markers. In: Sell S (ed) Serological Cancer Markers. The Humana Press, Totowa, NJ, chapter 11, 233-260
46. Kuo KC, Gehrke JC, Allen WC, Holsbeke M, Li Zh, Glinsky GV, Zumwalt RW, Gehrke GW: High-performance liquid chromatographic analysis of glycoamines in serum. J Chromatography 656: 295-302, 1994
47. Glinsky GV, Linetsky MD, Shemyakin VV, Markin VV, Liventsov VV, Ivanova AB: Structural analysis of a new class of humoral tumor markers: Characterization of 48 aminoglycoconjugates (glycoamines) isolated from rat and human blood plasma. J Tumor Marker Oncology 5: 107-118, 1990
48. Glinsky GV, Linetsky MD: Structural analysis of the carbohydrate core of amino-glycoconjugates (glycoamines) from blood plasma of oncological patients. J Tumor Marker Oncology 5: 137-160, 1990
49. Glinsky GV, Linetsky MD, Liventsov VV, Surmilo NI, Ivanova AB, Sidorenko MV, Vinnitsky VB: Glycoamine-synthesizing reaction: Molecular mechanism of the incorporation of monomers into aminoglycoconjugates. J Tumor Marker Oncology 5: 119-136, 1990
50. Glinsky GV: Glycodeterminants of melanoma cell adhesion. A model for antimetastatic drugs design. Critical Reviews in Oncology/Hematology 14: 1-13, 1993
51. Glinsky GV: The blood group antigen-related glycoepitopes: Biological functions and implications in immunogenesis, cancer, and AIDS pathogenesis. The Medical Intelligence Units, RG Landes Co., Austin, TX
52. Glinsky GV: The blood group antigens (BGA)-related glycoepitopes. A key structural determinants in immunogenesis and cancer pathogenesis. Critical Reviews in Oncology/ Hematology 12: 151-166, 1992
53. Linetsky MD, Semenova-Kobzar RA, Glinsky GV: The modifying influence of endogenous biopolymers, glycoamines, from the blood serum of BALB/C mice on aggregation properties of experimental rhabdomyosarcoma cells. Expl Oncol 13: 27-33, 1991
54. Nangia-Makker P, Thompson E, Hogan C, Ochieng J, Raz A: Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int J Oncol 7: 1079-1087, 1995
55. Frankel A, Buckman R, Kerbel RS: Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian carcinoma cells grown as multicellular tumor spheroids. Cancer Res 57: 2388-2393, 1997
56. Frankel A, Glinsky GV, Mossine VV, Buckman R, Kerbel RS: Antimetastatic synthetic glycoamines increase taxol's ability to induce programmed cell death in human ovarian carcinoma cells grown as multicellular tumor spheroids. Submitted
57. Mossine VV, Glinsky GV, Feather MS: The preparation and characterization of some Amadori compounds (1-amino-1-deoxy-D-fructose derivatives) derived from a series of aliphatic ω-amino acids. Carbohydrate Research 262: 257-270, 1994
58. Mossine VV, Glinsky GV, Barnes ChL, Feather MS: Crystal structure of an Amadori compound. N-(1-Deoxy-β-D-fructopyranos-1-yl)-glycine ('D-fructose-glycine'). Carbohydrate Research 266: 5-14, 1995